Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 79

Results For "TERI"

1720 News Found

IMCD Colombia acquires pharma API distributor Allianz
Supply Chain | May 03, 2023

IMCD Colombia acquires pharma API distributor Allianz

Allianz is ISO 9001:2015 certified and INVIMA certified for storage, sampling, dispensation, and distribution of APIs to the Colombian market


CPHI & PMEC China 2023 to see surge from pent up international ingredients demand
News | May 03, 2023

CPHI & PMEC China 2023 to see surge from pent up international ingredients demand

China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey


Innocan Pharma announces expansion to Lithuania, Latvia & Estonia markets
News | May 02, 2023

Innocan Pharma announces expansion to Lithuania, Latvia & Estonia markets

UAB Medexy's first order under the Distribution Agreement is for over 5000 units of SHIR and RELIEF&GO products


Mitsui Chemicals ‘Super-Bond’ dental adhesive to launch in Brazil
News | May 01, 2023

Mitsui Chemicals ‘Super-Bond’ dental adhesive to launch in Brazil

Super-Bond is made up of a polymerization initiator, a liquid and a polymer powder


RPG Life Sciences posts Q4 revenue at Rs 118.49 Cr
News | April 29, 2023

RPG Life Sciences posts Q4 revenue at Rs 118.49 Cr

Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23


Laurus Labs Q4 FY23 consolidated PAT drops to to Rs. 102.98 Cr
News | April 28, 2023

Laurus Labs Q4 FY23 consolidated PAT drops to to Rs. 102.98 Cr

Q4 results was challenging driven by steep fall in CDMO revenues and higher upfront cost of Capex projects and R&D projects


Yasmin and Mirena to take back seat from Bayer’s future drug strategy, says GlobalData
News | April 28, 2023

Yasmin and Mirena to take back seat from Bayer’s future drug strategy, says GlobalData

The news on a shift in its focus comes after the refinement of Bayer’s early innovation framework


Venus Remedies secures marketing authorization from UK MHRA for Cisplatin
News | April 27, 2023

Venus Remedies secures marketing authorization from UK MHRA for Cisplatin

Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country


USFDA lifts clinical hold on Phase 3 investigational new drug application for MaaT013
Drug Approval | April 24, 2023

USFDA lifts clinical hold on Phase 3 investigational new drug application for MaaT013

This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology


Sai Life Sciences opens research facility SSRL
News | April 22, 2023

Sai Life Sciences opens research facility SSRL

Fully equipped labs with 75-member team set-up and made operational in <100 days